home · filing · 0001477932-22-001045
8-K filed February 24, 2022, 6:59 PM ET
ticker UEEC
CIK 0001096938
other material
confidence high
sentiment negative
materiality 0.70
Two directors resign amid SEC investigation; COO steps down but remains in non-officer role
United Health Products, Inc.
Douglas Beplate resigns as director and chairman; Louis Schiliro resigns as director and COO, effective Feb 28, 2022.
Resignations tied to ongoing SEC investigation into 2017 revenue recognition; SEC may seek remedies against both individuals.
SEC private investigation since Nov 2018; company restated 2017-2018 financials in July 2020.
Company in dialogue with SEC staff for resolution; unable to predict outcome or enforcement actions.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2022-02-28
Filed February 24, 2022, 6:59 PM ET
Louis Schiliro submitted his resignation as a director and Chief Operating Officer of the Company, each effective on February 28, 2022
Effective 2022-02-28
Filed February 24, 2022, 6:59 PM ET
On February 18, 2022 Douglas Beplate submitted his resignation as a director of United Health Products, Inc.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.9
Louis Schiliro resigned as director and Chief Operating Officer at United Health Products, Inc..
Action resigned
Role director and Chief Operating Officer
Exact text from the filing
Louis Schiliro submitted his resignation as a director and Chief Operating Officer of the Company, each effective on February 28, 2022
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.9
Douglas Beplate resigned as director at United Health Products, Inc..
Action resigned
Role director
Exact text from the filing
On February 18, 2022 Douglas Beplate submitted his resignation as a director of United Health Products, Inc.
View on SEC.gov
Source: SEC EDGAR
accession 0001477932-22-001045
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.